IGC Pharma, Inc. (IGC) › RevenueIGC Pharma, Inc. (IGC) — RevenueAnnual figures by fiscal year, from SEC filings.2011: $4.07M2012: $4.20M2013: $8.03M2014: $2.27M2015: $7.68M2016: $6.37M2017: $580.4K2018: $2.19M2019: $5.12M2020: $4.07M2021: $898.0K2022: $397.0K2023: $911.0K2024: $1.34M2025: $1.27M$1.27M2011Revenue (USD)2025Fiscal YearRevenueChange YoY2025$1.27M-5.5%2024$1.34M+47.6%2023$911.0K+129.5%2022$397.0K-55.8%2021$898.0K-77.9%2020$4.07M-20.4%2019$5.12M+133.3%2018$2.19M+277.9%2017$580.4K-90.9%2016$6.37M-17.1%2015$7.68M+237.9%2014$2.27M-71.7%2013$8.03M+91.2%2012$4.20M+3.1%2011$4.07M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share